| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ng Carey is a Director at IMMX. Recent filings cover 3 purchases and 0 sales. Those positions are worth an estimated $230K at current prices.
Our model assigns Ng Carey a below-average insider score of 37/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -16.6%.
Ng Carey's largest disclosed position is in IMMX as Director, worth about $230K. Net of sales, the recent Form 4 record there shows accumulation of 45,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | IMMX Immix Biopharma, Inc. | Director | Buy | 10,000 | $1.86 | $18,600.00 | +100.0% | -14.7% | +19.5% | |
| Sep 14, 2023 | IMMX Immix Biopharma, Inc. | Director | Buy | 10,000 | $2.58 | $25,760.00 | New | +64.2% | -26.8% | |
| Dec 20, 2021 | IMMX Immix Biopharma, Inc. | Director | Buy | 25,000 | $5.00 | $125,000.00 | +2.5% | -31.7% | -42.5% |